A detailed history of Squarepoint Ops LLC transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 54,245 shares of MIST stock, worth $97,641. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54,245
Previous 54,684 0.8%
Holding current value
$97,641
Previous $72,000 13.89%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.29 - $1.65 $566 - $724
-439 Reduced 0.8%
54,245 $82,000
Q2 2024

Aug 14, 2024

BUY
$1.29 - $1.83 $70,542 - $100,071
54,684 New
54,684 $72,000
Q2 2023

Aug 14, 2023

BUY
$2.85 - $4.4 $130,227 - $201,053
45,694 New
45,694 $130,000
Q1 2021

May 17, 2021

SELL
$5.79 - $8.85 $136,835 - $209,152
-23,633 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$5.57 - $7.66 $131,635 - $181,028
23,633 New
23,633 $158,000

Others Institutions Holding MIST

About Milestone Pharmaceuticals Inc.


  • Ticker MIST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,010,900
  • Market Cap $54M
  • Description
  • Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...
More about MIST
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.